Home / Growth Plan – Subscription Terms & Conditions
Growth Plan – Subscription Terms & Conditions
By subscribing to the Growth Plan, you agree to the following plan-specific terms. These apply in addition to the MAI CDMO Legal Terms.
With the Growth Plan you get:
Note: Access to the network and projects facilitates outreach but does not guarantee any response, lead volume, or awarded projects.
The Growth Plan is €49.99 per month, billed annually at a total of €599.88. VAT not included.
Available payment methods:
The subscription automatically renews at the end of each term unless cancelled by the subscriber at least thirty (30) days in advance.
Fees may be updated upon prior notice. If the subscriber does not accept the revised fee, it may cancel the subscription before the effective date.
The subscriber shall be responsible for keeping its contact details up to date.
In the event of non-payment, a grace period of forty-eight (48) hours shall be granted. If payment is not received in the provider’s account within this period, the subscription will automatically switch to the Basic Plan, with reduced features. This clause is established pursuant to the freedom of contract recognized in the Spanish Commercial Code (arts. 1 et seq.) and Civil Code (art. 1,261), as well as Law 7/1998, of April 13, on General Conditions of Contracting, last updated 16/03/2019, ensuring clarity, precision, and transparency for the parties.
2025-11-05
Mabion is a CDMO company specializing in the advanced manufacturing and development of biological products, with extensive experience in monoclonal antibodies. Founded in 2007 and headquartered in the EU, in Poland.
See more
2025-10-15
Cultiply is a specialized biotechnology company dedicated to industrial microbiology and fermentation technologies for biological processes. This company is focused on offering a complete innovation platform, from the idea phase to industrial scaling.
See more
2025-09-22
Connecting Leaders in Biologics Manufacturing
See more
The Hérouville-Saint-Clair site, located near Caen, in Normandy, specializes in the manufacture and filling of injectable and non-injectable sterile liquid products. It has a pharmaceutical surface area of 17,900 m2 over 10 hectares and employs 290 people.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Manufacturing services,...
Batch Size / Reactor: Small, Medium
Certifications: EMA (EU GMP), FDA (cGMP), NMPA (China GMP), ANVISA...
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK), TGA...
Tubilux Pharma: registered office; manufacturing facility
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Commercial (Phase IV), Human, Veterinary
Services: Regulatory services, Development services,...
Batch Size / Reactor: Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), TGA (Australia GMP),...
Markets: FDA (USA), EMA (EU), TGA (Australia), ANVISA...
Sterile manufacturing solutions (small molecules) in flexible bags and vials.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
Lannetts main manufacturing site sits in Seymour, Indiana, and includes capabilities for Oral Solid Dose (OSD) and Liquids.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP), FDA (cGMP), Health Canada (Canada...
Markets: COFEPRIS (Mexico), FDA (USA), EMA (EU), PMDA...
Reliable CDMO partner for aseptic manufacturing and lyophilization of biologics and injectable drugs.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services,...
Batch Size / Reactor: N/A
Certifications: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Markets: INVIMA (Colombia), FDA (USA), EMA (EU), MHRA (UK),...
Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Markets: FDA (USA), EMA (EU)
Commercial API Small Molecules Synthesis
Activity: CHEMICAL-SYNTHETIC manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services
Batch Size / Reactor: Small, Medium, Large
Certifications: ISO, FDA (cGMP), ECOVADIS
Markets: FDA (USA), EMA (EU), PMDA (Japan), Health Canada...
CDMO Sterile Oncology Drugs
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Manufacturing services, Analytical / QC services,...
Batch Size / Reactor: Small, Medium, Large
Certifications: EMA (EU GMP)
Markets: EMA (EU)
If you have any questions or suggestions, click here. We will be happy to assist you.
